- Home
- BB vs BCRX Comparison
BB vs BCRX Comparison
Compare BB & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BB | BCRX |
|---|---|---|
| Founded | 1984 | 1986 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1999 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BB | BCRX |
|---|---|---|
| Price | $3.56 | $9.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | $4.90 | ★ $20.82 |
| AVG Volume (30 Days) | ★ 7.9M | 6.1M |
| Earning Date | 04-09-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 40.91 | ★ 381.40 |
| EPS | 0.05 | ★ 1.21 |
| Revenue | ★ $534,900,000.00 | $25,186,000.00 |
| Revenue This Year | $4.19 | N/A |
| Revenue Next Year | $7.63 | $12.55 |
| P/E Ratio | $69.20 | ★ $7.45 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.81 | $6.00 |
| 52 Week High | $5.32 | $11.31 |
Technical Indicators
Market Signals| Indicator | BB | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.82 | 60.78 |
| Support Level | $3.55 | $7.85 |
| Resistance Level | $3.59 | $10.32 |
| Average True Range (ATR) | 0.12 | 0.57 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 93.62 | 46.50 |
Price Performance
Historical ComparisonAbout BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.